Healthcare -
Medical - Diagnostics & Research - NASDAQ - US
$ 14.21
1.65 %
$ 1.82 B
Market Cap
-23.3
P/E
Price Target
Average
35.72%
Revenue Forecast
Estimate
20.81%
EBIT
Estimate
12.23%
Net Income
Estimate
65.15%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
NeoGenomics, Inc.
Wall Street analysts predict an average 1-year price target for NEO of $19.3 , with forecasts ranging from
a
low of
$18 to a high of $21 .
NEO Lowest Price Target
Wall Street Target
18 USD
26.67%
NEO Average Price Target
Wall Street Target
19.3 USD
35.72%
NEO Highest Price Target
Wall Street Target
21 USD
47.78%
REVENUE FORECAST
Revenue Forecast Chart NEO
EBIT FORECAST
EBIT Forecast Chart NEO
NET INCOME FORECAST
Net Income Chart NEO